Articles and Information
Form 7 Monthly Progress Report April 2024
Form 7 Monthly Progress Report April 2024 Name of Listed Issuer: Trading Symbol: Number of
April 9, 2024
Menu
Menu
- News
BioMark AGM
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
News
BIOMARK TO ADVANCE DEVELOPMENT OF CANCER TREATMENT FOR GLIOBLASTOMA
BIOMARK TO ADVANCE DEVELOPMENT OF CANCER TREATMENT FOR GLIOBLASTOMA The Company secured collaborative research funding
April 9, 2024
Articles and Information
Form 7 Monthly Progress Report February 2024
Form 7 Monthly Progress Report January 2024 Name of Listed Issuer: Trading Symbol: Number of
March 5, 2024
News
BIOMARK PartnerS with RUBIX LS to Advance Blood-based Cancer Screening in Underserved Communities
Vancouver, British Columbia – (February 28, 2024) – BioMark Diagnostics Inc. (“BioMark” or the “Company”)
February 28, 2024
News
Theresa Peterson Joins BioMark’s Advisory Team
Vancouver, British Columbia – (February 26, 2024) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX, FSE:
February 28, 2024
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Pages
Latest Posts
Menu
Site Policies
Menu